Allarity Therapeutics, Inc. Share Repurchase Authorization
Allarity Therapeutics, Inc. (ALLR) had Share Repurchase Authorization of $5 as of 2025-03-03, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-03-30
- 2025-03-03: Stock Repurchase Program Authorized Amount1 $5.00; Stock Repurchase Program Authorized Amount1 as first filed $5.00M.
| Period end | Stock Repurchase Program Authorized Amount1 | Stock Repurchase Program Authorized Amount1 as first filed |
|---|---|---|
| 2025-03-03 | $5.00 10-K · filed 2026-03-30 | $5.00M 10-Q · filed 2025-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |